id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-2007-E-0281-0010,FDA,FDA-2007-E-0281,AstraZeneca  AB - Patent Term Extension Application - Maintenance Fee Statement,Supporting & Related Material,APP-Application,2008-10-31T04:00:00Z,2008,10,,,2026-01-06T23:28:51Z,,0,0,090000648042b443
FDA-2007-E-0281-0011,FDA,FDA-2007-E-0281,Patent Term Extension Application - Attachment 3,Supporting & Related Material,APP-Application,2008-10-31T04:00:00Z,2008,10,,,2026-01-06T23:29:31Z,,0,0,090000648042b444
FDA-2007-E-0281-0012,FDA,FDA-2007-E-0281,Patent Term Extension Application - Chronology of Significant Activities,Supporting & Related Material,APP-Application,2008-10-31T04:00:00Z,2008,10,,,2026-01-06T23:29:52Z,,0,0,090000648042b446
FDA-2007-E-0281-0013,FDA,FDA-2007-E-0281,Patent Term Extension Application - Attachment 2,Supporting & Related Material,APP-Application,2008-10-31T04:00:00Z,2008,10,,,2026-01-06T23:30:17Z,,0,0,090000648042b447
FDA-2007-E-0281-0009,FDA,FDA-2007-E-0281,Patent Term Extension Application - Exhibit F,Supporting & Related Material,APP-Application,2008-10-31T04:00:00Z,2008,10,,,2026-01-06T23:28:09Z,,0,0,090000648042b442
FDA-2007-E-0281-0006,FDA,FDA-2007-E-0281,AstraZeneca  AB - Patent Term Extension Application,Other,APP-Application,2008-10-31T04:00:00Z,2008,10,2008-10-31T04:00:00Z,,2026-01-06T23:24:10Z,,0,0,090000648042b445
FDA-2007-E-0281-0008,FDA,FDA-2007-E-0281,Patent Term Extension Application - Attachment 1,Supporting & Related Material,APP-Application,2008-10-31T04:00:00Z,2008,10,,,2026-01-06T23:26:13Z,,0,0,090000648042b43f
FDA-2007-E-0281-0007,FDA,FDA-2007-E-0281,USPTO to White & Case LLP - Notice of Final Determination-Ineligible,Other,ADV-Denial of Application,2008-10-31T04:00:00Z,2008,10,2008-10-31T04:00:00Z,,2026-01-06T23:25:22Z,,0,0,09000064806ff96c